Clinical Trial Update: Trial of Captafer® vs. Oral Iron Sulfate in the Treatment of Iron Deficiency Anemia in Patients With IBD [Phase 4]

View source ↗

Summary

A Phase 4 trial compares Captafer with oral iron sulfate for treating iron deficiency anemia in patients with inflammatory bowel disease; the current status of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Iron Deficiency Anemia

Drugs mentioned

• Captafer
• Oral Iron Sulfate (ferrous sulfate)

Snippet

Sponsor: American University of Beirut Medical Center | Conditions: Iron Deficiency Anemia, Inflammatory Bowel Disease | Phase 4 | Status: UNKNOWN